Macquarie Group’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-60
Closed -$13K 2418
2017
Q4
$13K Buy
+60
New +$14.2K ﹤0.01% 2236

Other funds holding PHXM

Macquarie Group's PHXM Position: Q1 2018 in Review

Macquarie Group sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q1 2018, closing a stake of 60 shares — an estimated $13K sold.

Macquarie Group first reported a position in PHXM in Q4 2017 and held it in 1 quarter. The position peaked at $13K in Q4 2017. 8 funds tracked by Wall St. Rank hold PHXM as of Q1 2018.

  • Macquarie Group reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Macquarie Group sold 60 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q1 2018, an estimated $13K.
  • Macquarie Group first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 1 quarter.
  • Macquarie Group's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $13K in Q4 2017.
  • 8 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.